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Abstract
The main challenge in hepatic tissue engineering is the fast dedifferentiation of primary hepatocytes in vitro. One successful
approach to maintain hepatocyte phenotype on the longer term is the cultivation of cells as aggregates. This paper
demonstrates the use of an agarose micro-well chip for the high throughput generation of hepatocyte aggregates, uniform
in size. In our study we observed that aggregation of hepatocytes had a beneficial effect on the expression of certain
hepatocyte specific markers. Moreover we observed that the beneficial effect was dependent on the aggregate dimensions,
indicating that aggregate parameters should be carefully considered. In a second part of the study, the selected aggregates
were immobilized by encapsulation in methacrylamide-modified gelatin. Phenotype evaluations revealed that a stable
hepatocyte phenotype could be maintained during 21 days when encapsulated in the hydrogel. In conclusion we have
demonstrated the beneficial use of micro-well chips for hepatocyte aggregation and the size-dependent effects on
hepatocyte phenotype. We also pointed out that methacrylamide-modified gelatin is suitable for the encapsulation of these
aggregates.
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Introduction
Upon isolation of their native micro-environment, hepatocytes
rapidly lose their viability and metabolic functions. [1] This limits
or prevents their use for clinical, engineering and research
purposes. The prolonged maintenance of hepatocyte phenotype
could e.g. lead to the development of an engineered donor tissue,
bioartificial liver device, more efficient transplantation methods,
the development of more reliable in vitro models thereby
improving drug toxicity screening, liver disease research and
many more. [2,3]
To improve hepatocyte performance many strategies have been
addressed. One approach is the cultivation of hepatocytes as
aggregates, allowing enhanced cell-cell contacts in a three
dimensional context. Cell-aggregates can be considered as
micro-tissues and are more representative for liver tissue than
conventional two dimensional cell cultures. Different techniques
such as static cell culture on non-adherent surfaces or micro
patterned surfaces, hanging drop and rotary culture systems have
been used for creating hepatocyte aggregates with variable
dimensions. [4] These studies have demonstrated that the
cultivation of hepatocytes as aggregates improves many of their
metabolic functions such as cytochrome P450 activity, albumin
secretion, urea production, glutathione S-transferase activity, etc.
[5,6] [4,7]
Most living tissues, including the liver, are composed of
repeating cellular units on a scale of hundreds of microns.
Artificially generated three dimensional cell aggregates comprising
hepatocytes could potentially serve as functional building blocks
for the creation of larger constructs. [8] Assembly of these building
blocks into larger constructs with more relevant dimensions, can
be obtained by self-assembly or assembly in a more directed way
using biomaterials to guide this process. [9,10] In this context, the
immobilization and organization of the aggregates at high density,
while allowing mass transport of nutrients and metabolites for
hepatocyte survival and function, could be useful. [4],[8]
In this study, we used a microwell-based tissue culture platform
to generate large quantities of hepatocyte aggregates of predefined
dimensions and shapes. We observed that aggregate dimensions
affect the overall performance of the hepatocytes and selected the
most optimal aggregation parameters. Combining these well
defined primary hepatocyte aggregates with a gelatin methacry-
lamide hydrogel allows the encapsulated aggregates to maintain a
proper hepatocyte phenotype. The present work demonstrates the
generation of large amounts of relatively small aggregates that can
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be organized into larger constructs by encapsulation in a gelatin
hydrogel. [11,12]
Materials and Methods
The study protocol was approved by the Ethical committee for
Animal Care and Use of Ghent University (permit number ECD
12/42). Institutes of Health principles of laboratory animal care
(NIH) were followed.
2.1. Cell culture and isolation of primary hepatocytes
HepG2 cells were maintained in DMEM Glutamax supple-
mented with 10% v/v FBS, 50 U/ml penicillin and 50 mg/ml
streptomycin, all provided by Life Technologies.
Primary mouse hepatocytes were isolated from adult mouse
livers (ICR CD-1 mice, 8–14 weeks of age, Harlan Laboratories).
The animals were anaesthetized with ketamin/xylazin and died
during the perfusion procedure. The hepatocytes were isolated
from the liver using a two-step collagenase perfusion method,
followed by percoll gradient purification as described by Conc¸alves
et al [13]. After isolation, cells were immediately seeded in micro-
wells, or well plates coated with 0.1% collagen (BD Bioscienses), in
order to compare three dimensional with two-dimensional cell
culture.
Primary hepatocytes were cultured in William’s E medium (Life
Technologies), supplemented with L-glutamine (292 mg/ml) (Life
Technologies), glucagon (7 ng/ml) (sigma), insulin (0.5 mg/ml)
(sigma), hydrocortisone (25 mg/ml), EGF (10 ng/ml), 10% v/v
FBS (Life Technologies), 50 U/ml penicillin (Life Technologies)
and 50 mg/ml streptomycin (Life Technologies).
Both the HepG2 cells and the primary hepatocytes were
maintained in a humidified 5% CO2-containing atmosphere at
37uC.
2.2. Micro-well synthesis and micro-aggregate formation
To produce the non-adherent agarose micro-wells, sterilized
powder Ultrapure Agarose (Life Technologies) was dissolved (3%
w/v) and heated in PBS. The liquid agarose solution was added to
a tailor-made, negative polydimethylsiloxane mold (PDMS, as
described previously [14,15]) and left to solidify at RT. After
cooling, the gels were separated from the moulds and subsequently
transferred into 12 well culture plates. Single cell suspensions of
various densities (detailed information in table 1 and table 2) were
seeded in the chip containing the micro-wells. After seeding,
formation of micro-aggregates was supported by centrifugation for
1 min at 1500 rpm to let the cells settle into the bottom of the
micro-wells. Culture medium was replenished 24 h after seeding
and cells were left in culture for 3 days to allow formation of stable
micro-aggregates. The aggregates were harvested at different time
points, as indicated in the results section.
Aggregate diameter, perimeter (p) and aggregate area (A) was
determined using Xcellence image software. Subsequently circu-
larity was calculated using the formula fcirc= (4pA)/p
2.
Aggregate volume was determined based on the diameter and
the volume formula of a spherical object. The number of cells per
aggregates was estimated, based on the number of microwells per
chip and the amount of seeded cells per chips. All aggregate
characteristics and parameters are represented in table 1 and
table 2.
2.3. Aggregate encapsulation
Gelatin methacrylamide with a degree of substitution (DS) of
65% was used to encapsulate aggregates as described earlier.[16]
Briefly, aggregates (2300 aggregates/ml) were mixed in dissolved
gelatin (10% w/v in PBS) with 2 mol % Irgacure 2959 photo-
initiator, as calculated relative to the (photo-sensitive) methacry-
lamide side groups. The aggregate-gelatin mixture was transferred
(200 ml/well) into 48 well plates (Greiner Bio-one) and left for
physical gelation during 30 min. Photocross-linking was carried
out by exposure to UV-A light (365 nm, 2 mW/cm2, UVP Inc.)
for 10 min. After cross-linking, culture medium was added and
refreshed every 24 h.
2.4. Cell viability
To assess the cell viability, aggregates were washed twice with
PBS and incubated for 10 minutes with 2 mg/ml calcein-AM
(AnaSpec) and 2 mg/ml propidium iodide (PI) (Sigma). After
washing in PBS for 10 min, cell viability was evaluated by
determining the ratio of green (live) versus red (dead) cells using an
inverted fluorescence microscope (Olympus IX81) equipped with
Xcellence software (Olympus).
2.5. Histology
Samples were fixed (4% paraformaldehyde) and embedded in
paraffin. Five mm thick sections were stained with hematoxilin and
eosin (HE), Periodic acid Schiff (PAS) or immunostained (IHC), all
at room temperature.
For IHC staining, endogenous peroxidase was quenched using
3% v/v H202 for 1 h, and a 30 min treatment with blocking
reagent (1% w/v BSA, 0.2% v/v Tween 20 in PBS) was
performed. The samples were incubated with the primary
antibody (dilution 1:100) for 2 h and subsequently with the
Table 1. Overview of the applied parameters for HepG2 cells and primary hepatocytes and their characteristics.
Seeded number
of cells/chip
Mean aggregate
diameter (mm)
Mean number of
cells/aggregate
Mean aggregate
volume (mm3)
Diameter of micro-wells
in the chip
1000000 307613 629 15120449 400 mm
750 000 29769 472 13745009 400 mm
500 000 261615 314 9255967 400 mm
250 000 23167 157 6479261 400 mm
1 000 000 166611 87 2408105 200 mm
750 000 15769 175 2010823 200 mm
500 000 14267 262 1489732 200 mm
250 000 11669 349 810959 200 mm
doi:10.1371/journal.pone.0105171.t001
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secondary antibody (dilution 1:200) for 30 min. A goat anti-mouse
albumin antibody (p20, Santa Cruz) and a rabbit anti-mouse
HNF4a (H-171, Santa Cruz) was used as primary antibody for
albumin and HNF4a respectively. A 3,3-diaminobenzidine
tetrahydrochloride substrate was used to visualize the horse radish
peroxidase coupled secondary antibody. After hematoxylin
staining and mounting, the samples were visualized under the
microscope. For HNF4a the whole staining procedure was
preceded by antigen retrieval using citrate buffer (pH 6.00).
For PAS stain, the samples were treated with 1% v/v periodic
acid for 15 min. After washing with PBS, samples were exposed to
Schiff reagent (Sigma) for 30 minutes in the dark. After rinsing in
water, the slides were stained with hematoxylin and mounted.
For transmission electron microscopy, aggregates were fixed
with glutaraldehyde, postfixed with OsO4 and embedded in epoxy
resin. Sections (70 mm thick) were evaluated by a Jeol 1200 EX II
electron microscope.
2.6. Cytochrome activity
Cyp3A4 activity of the primary hepatocyte aggregates was
analyzed using a P450-Glo-CYP3A assay (Promega) according to
the manufacturer’s protocol for cell-based assays. After 72 h
culture in the micro-wells, aggregates were exposed for 1 h to
culture media containing luciferin-IPA (1:1000). After 1 h, an
equal volume of the liquid was transferred to a 96 well plate and
incubated with an equal volume of detection reagent. After
20 min, luciferase activity was detected using a Wallac 1420
Victor3 multilabel counter (Perkin Elmer). The detected lumines-
cence was normalized for the amount of cells (MTT assay).
Background subtraction was performed with culture medium
considered as negative control.
2.7. Albumin secretion
To assess albumin secretion, media samples were collected at
different time points. After omitting cross-reactivity for bovine
albumin, the amount of secreted albumin was determined using a
mouse albumin ELISA quantitation kit or a human albumin
ELISA quantitation kit (Bethyl laboratories, Inc., UK) and
normalized for the amount of cells using an MTT assay.
2.8. MTT assay
The hepatocytes were incubated with a 0.5 mg/ml solution of
MTT (Calbiochem) in culture medium for four hours in the dark
in a 5% CO2 incubator at 37uC. After discarding the MTT
solution, the formed formazan crystals were dissolved in isopro-
panol-0.04N HCl supplemented with 1% v/v Triton X100
(Sigma). Subsequently the absorbance was measured at 580 nm
using an EL800 Universal microplate reader (BioTek instruments
Inc.) and compared to a standard curve.
2.9. Real Time Polymerase chain reaction (RT-PCR)
Total RNA was extracted from hepatocyte aggregates using
TRI Reagent (Sigma-aldrich) and treated with DNAse digestion
kit (Invitrogen). RT Core Kit (Eurogentec) was used to synthesize
cDNA, according to the manufacturer’s protocol. A 7500 Fast
Real-Time PCR system (Applied Biosystems) and a SYBR Green
PCR kit (Eurogentec) were used according to the manufacturer’s
instructions and protocols. GAPDH expression was used as stable
housekeeping marker for reference. The relative gene fold changes
were determined by the 22DDCt method. For comparative gene
expression analysis of free floating aggregates gene expression was
compared to expression levels of freshly isolated hepatocytes.
Additionally, to assess the effect of hydrogel embedding, encap-
sulated hepatocyte aggregates were compared to aggregates before
encapsulation (day 3). Primer sequences are depicted in table S1
and S2.
2.10. Statistical Analysis
Differences between groups were explored by one-way
ANOVA, followed by a Student t-test using the statistical package
GraphPad Prism 4 (San Diego California, USA).
Results
3.1. Development of micro-aggregates with controlled
size
Tailor-made PDMS molds were used to generate agarose
microwell-containing chips. Briefly, liquid agarose was poured on
top of PDMS molds containing micro-sized cylindrical sticks. After
solidifying, the PDMS molds were removed from the agarose
resulting in agarose chips containing micro-sized wells. (illustrated
fig. S1) The fabrication of these micro-well-containing chips
resulted in micro-well array chips containing 2865 or 1585 wells
with a diameter of 0.2 or 0.4 mm respectively in agarose. After
fabrication, the chips were placed in a 12 well plate and used for
controlled hepatocyte aggregation.
First, the micro-aggregation procedure was optimized using
HepG2 cells. Although this human hepatocellular carcinoma cell
line is less representative of the in vivo situation, these cells are
user-friendly, robust and aggregate easily while maintaining some
hepatocyte specific functions. Subsequently the procedure was
adapted and performed using primary mouse hepatocytes. The
micro-aggregation behavior of and its effect on these cells was
evaluated and compared.
For both cell types, aggregate formation started from day 1
(fig. 1A). In addition, we observed that stable aggregates were
formed within 3 days, which was accompanied by an increase in
E-cadherin expression (fig. 1B). By varying parameters such as
micro-well diameter, cell number and cell type, aggregates with
different dimensions were obtained (fig. 1C–E). All applied
parameters in relation to and affecting aggregate dimension are
Table 2. Overview of the applied parameters for primary hepatocytes and their characteristics.
Seeded number
of cells/chip
Mean aggregate
diameter (mm)
Mean number
of cells/aggregate
Mean aggregate
volume (mm3)
Diameter of micro-wells
in the chip
150 000 185616 94 3336782 400 mm
75 000 90613 47 385917 400 mm
150 000 95613 52 452331 200 mm
75 000 6068 26 111241 200 mm
doi:10.1371/journal.pone.0105171.t002
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listed in tables 1 and 2. Aggregate diameters (Q) varied between
100 and 300 mm for HepG2 cells and between 50 to 200 mm for
primary hepatocytes. The linear relation between aggregate
volume and cell number observed in fig.1C–D, the constant
circularity values starting from day 2 (fig. 1F) and microscopic
observation indicate that the aggregates were spherical and
uniform in size.
3.2. Hepatocyte specific performance is enhanced and is
size dependent in micro-aggregates
For HepG2 aggregates, size dependent correlation of hepato-
cyte gene expression markers such as albumin, HNF4a and TTR
was observed (fig. S6) and albumin secretion (fig. S7) was clearly
enhanced for all conditions. It appeared that HepG2 cells are not
very sensitive for variations in aggregate size shortly after
aggregate formation (day 3, fig. S2), however 7 days after
aggregate formation the smaller aggregates (Q#23167 mm)
maintained higher hepatocyte-specific gene expression levels than
the larger aggregates (Q$261615 mm). At this time point a
substantial amount of dead cells was observed in the center of the
larger (Q$261615 mm diameter) aggregates (fig. S3).
The gene expression and protein secretion of albumin, an
important serum protein produced by the liver, was evaluated and
normalized using primary hepatocyte aggregates and compared to
primary hepatocytes plated on collagen 1 coated tissue culture
plates (TCP) 3 days after isolation (fig. 2 A–B). In some aggregates
both gene expression as well as protein secretion was significantly
(p,0.05) enhanced compared to the control culture. However,
clear differences in both secretion (fig. 2B) and gene expression
(fig. 2A) were observed between aggregates of different sizes with a
significant enhancement of both secretion (p,0.01) and gene
expression (p,0.001) for 95613 mm diameter aggregates. Analysis
of the albumin secretion at day 7 after isolation indicated a general
drop in albumin secretion for all conditions. However the
differences between aggregates of different sizes remained and
the 95613 mm aggregates maintained the highest albumin
secretion levels. (fig. S4)
A significant (p,0.05) improvement, compared to cells cultured
as monolayers, in both cyp3A enzyme activity (fig. 2D) and gene
expression (fig. 2C) was noticed for the 95.2612.5 mm and
Figure 1. Formation of hepatocyte micro-aggregates in agarose microwells. (A) Aggregate formation over time for both HepG2 cells and
primary hepatocytes. (B) E-cadherin gene expression in primary hepatocytes during aggregate formation (C–D) Correlation between number of cells,
aggregate diameter (squares) and volume (triangles) for the formation of HepG2 cell aggregates in 200 (C) and 400 mm (D) microwells, n = 3. (E)
Correlation between number of primary cells, aggregate diameter (solid line) and volume (dotted line) for the formation of primary hepatocyte
aggregates in 200 (white squares) and 400 mm (black squares) microwells, n = 3. (F) circularity of aggregates during culture for HepG2 cells (squares)
and primary hepatocytes (triangles), n = 3.
doi:10.1371/journal.pone.0105171.g001
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185616 mm aggregates, while this improvement is less clear for
the 6068 mm aggregate, 3 days after isolation. Different aggregate
sizes lead to different cyp3A performance with the medium sized
aggregates (Q 95613 mm, obtained by seeding 150 000 cells in the
200 mm micro-well) displaying the highest activity and the smallest
aggregates (Q 6068 mm) showing the lowest activity 3 days after
isolation. The cyp3A4 enzyme activity at day 7 (fig. S5) showed a
decrease for all conditions and for cells cultivated as monolayers
the activity was not detectable. For the aggregates, the 95613 mm
aggregates displayed the highest cyp3A4 activity when compared
to the 185616 mm and 6068 mm aggregates.
It was clear that hepatocyte phenotype depends on aggregate
parameters and increasing aggregate dimensions did not neces-
sarily lead to better performance. Live/dead staining of the
different aggregates indicated excellent cell viability in the
aggregates, however more dead cells were observed in the largest
aggregates (Q$185616 mm, fig. 2E) when compared to the other
aggregates (fig. 2F). This observation could indicate nutritional/
waste diffusion limitations and explain why no clear relation
between hepatocyte performance and aggregate size was observed.
3.3. Long term hepatocyte function is affected by
aggregate dimensions
Since aforementioned results indicated that 95613 mm diam-
eter primary hepatocyte aggregates performed most optimal, these
were further evaluated. The hepatocyte specific function (fig. 3A)
of two-dimensional cultured hepatocytes and hepatocyte aggre-
gates were compared to freshly isolated non-cultured hepatocytes
over time. At day 10 and 15, no expression of the genes of interest
was detected for two-dimensional cultured cells (fig. 3A, TCP
N.D.). For all examined genes, aggregates displayed a clear and
significant upregulation of albumin, connexin32 (Cx32), hepato-
cyte nuclear factor 4a (HNF4a), E-cadherin, cyp3A, cytochrome
Figure 2. Evaluation of hepatocyte phenotype for different micro-aggregate sizes. (A) Gene expression of albumin. Gene expression levels
of albumin were determined for different micro-aggregation conditions and compared to cells cultured on tissue culture plastic (TCP). (B) Albumin
secretion at day 3 after isolation for different micro-aggregation conditions. Data are mean 6 SD, n = 3, **p,0,01; compared to cells cultivated as
monolayers (TCP). (C) Gene expression of CypA3. Gene expression levels of Cyp3A for different aggregate dimensions compared to cells cultured on
tissue culture plates (TCP). Gene expression of Cyp3A was determined after 72 hours of cultivation in the micro-wells. Data are mean RQ 6 SD, n = 3.
*p,0.05; **p,0.01 (D) Induced cytochrome 3A4 activity in aggregates of different diameter versus cells cultured on tissue culture plastic. Cyp3A4
activity was quantified after treatment with an inducing agent (hydrocortisone) using a luciferase based assay after 3 days of isolation. Data are mean
6 SEM, n = 3. *p,0,05; **p,0,01; ***p,0,001 compared to cells cultured as monolayers (TCP). (E–F) Live/dead stain of micro-aggregates with diameters
of 200 mm (E) and 100 mm (F). Dead cells are stained red, while viable cells are stained green. scale bar = 50 mm.
doi:10.1371/journal.pone.0105171.g002
High Throughput Generation of Hepatocyte Micro-Aggregates
PLOS ONE | www.plosone.org 5 August 2014 | Volume 9 | Issue 8 | e105171
1A2 (cyp1A2) compared to cells in monolayers. The gene
expression of HNF4a, an important transcription factor for the
expression of hepatocyte specific genes, was maintained at a
similar level in the aggregate as in freshly isolated hepatocytes, and
increased over time. Gene expression of Cx32, indicative of gap
junctions between cells, and cyp3A, indicative of active phase I
metabolism, had decreased. Gene expression of E-cadherin,
important for cell-cell adhesion and required for aggregate
formation and stability, was upregulated in aggregates when
compared to freshly isolated cells and remained stable during 15
days of culture.
The synthesis of albumin and HNF4a protein in the 100 mm
aggregate was visualized using IHC staining and storage of
glycogen was determined by PAS staining. Albumin secretion was
significantly enhanced (2-fold increase) as compared to the plated
cells at all time points.
Transmission electron microscopy (fig. S8) showed the presence
of narrow contacts (desmosomes and gap junctions) between the
cells and normal cell morphology with numerous mitochondria,
abundant RER within the cytoplasm of hepatocytes cultured for
10 days in aggregates.
3.4. Micro-aggregates remain viable and functional upon
encapsulation in gelatin
For tissue engineering purposes, the creation of larger constructs
might be desirable (i.e. for the creation of bio-artificial liver
devices, incorporation in a bioreactor). To organize these micro-
aggregates at a larger scale, encapsulation and immobilization in a
hydrogel could be a useful approach.
Therefore aggregates (Q 95613 mm) were encapsulated and
cultured in a methacrylamide-gelatin hydrogel and gene expres-
sion and cell metabolism were compared with non-encapsulated
aggregates. The viability of the immobilized aggregates compared
to the non-encapsulated aggregates indicated that primary
hepatocytes were not affected by the encapsulation procedure.
Most of the aggregates maintained their rounded morphology
while some cellular outgrowth was observed at day 10 of culture
(fig. 4A and B).
Similar gene expression profiles (fig 4D) between encapsulated
and non-encapsulated aggregates were found, suggesting that
gelatin encapsulation did not affect hepatocyte functions.
Immunohistochemistry on encapsulated aggregates demonstrate
that expression of albumin and HNF4a protein was maintained
during 10 days of culture. Fig. 4C depicts the cumulative albumin
Figure 3. Evaluation of hepatocyte phenotype maintenance in micro-aggregates. (A) Gene expression analysis using real-time PCR. Gene
expression of HNF4a, Cyp3A, Cyp1A2, E-cadherin and connexin 32 (Cx32) were determined for cells cultured on tissue culture plastic (white bars, TCP)
and aggregates (black bars, AGG) at day 3, 6, 10 and 15 after isolation. The gene expression was normalized using GAPDH as stable housekeeping
gene and related to freshly isolated hepatocytes (value = 1). Data are mean RQ 6 SD, compared to freshly isolated, non cultured hepatocytes, n = 3. *p,
0.05; **p,0.01. (B) Albumin, HNF4a, and PAS staining to visualize glycogen storage day 3 and day 10. scale bar = 50 mm. (C) Albumin secretion of
plated cells and microaggregates determined by ELISA. Albumin secretion during 24 hours at day 3, 10 and 15 was evaluated for cells cultured on
tissue culture plastic (white bars, TCP) and aggregates (black bars, AGG). * p,0.05, ***p,0.001
doi:10.1371/journal.pone.0105171.g003
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secretion profile of the immobilized aggregates and suggests that
albumin is secreted 21 days during cell culture.
Discussion
Currently, several cell aggregation methods have been described
in literature e.g. static cell culture on non-adherent surfaces,
hanging drop and rotary culture systems leading to variable
aggregate dimensions mostly involving cumbersome technical
handling of cells and culture media.[5,6] The creation of large
amounts of aggregates with predefined, controlled and uniform
sizes in a reproducible and accurate manner is hard to control with
the above-mentioned culture techniques and limits further
development of aggregate based, or modular tissue engineered
constructs. In this study, the potential of an agarose micro-well
system has been investigated which allows controlled aggregation
of primary hepatocytes into a large number of uniform cell
aggregates with predefined dimensions (650–100–180 mm) within
3 days after cell seeding and isolation from mouse livers. In
addition, we confirm that HepG2 cells, a commonly used
hepatocyte cell line, benefit from aggregation and three dimen-
sional cell culture and that their function is increased in the larger
aggregates used in this study. This is in line and complementary
with studies reporting differentiation and increased expression of
several hepatocyte specific markers (such as increased albumin
secretion, urea, …) in HepG2 spheroids.[7,17]
For the practice of aggregate based tissue engineering (e.g. the
directed assembly of aggregates into larger constructs using
bioprinting applications), aggregate uniformity might be impor-
tant. In these approaches, the use of aggregates with predefined
sizes might be desirable as well. Some papers report the improved
functional performance of uniform hepatocyte aggregates, formed
in PDMS or polystyrene micro-wells. However, the success of
these systems was dependent on rotary culture systems and in both
papers only aggregates with variable dimensions (ranging from
100–300 mm) have been used for further functional evaluation,
assuming that all aggregates perform in the same way.[4,18]
Figure 4. Evaluation of micro-aggregates after encapsulation in a gelatin hydrogel. (A) Live/dead stain of aggregates encapsulated in
gelatin hydrogel at day 10. scale bar = 50 mm (B) Stainings of the immobilized micro-aggregates at day 10 after isolation. The pictures represent
stainings for albumin and HNF4a and PAS staining to visualize glycogen storage. Pictures were recorded at 20 x magnification at day 10, scale
bar = 50 mm. (C) Cummulative albumin secretion deterimend by ELISA. Albumin secretion of the immobilized cells was evaluated during 21 days of
cultivation by ELISA. Data are mean 6 SD, n = 3. (D) Real-time PCR for gene expression analysis after immobilization in the hydrogel. Gene expression
levels of HNF4a, Cyp3A4, Cyp1A2, E-cadherin and connexin 32 (Cx32) were determined for not immobilized (white bars, not encapsulated) and
immobilized micro-aggregates (black bars, encapsulated) at day 3, 6, 10 and 15 after isolation. The expression values were normalized using GAPDH
as stable housekeeping gene and compared to aggregate values before encapsulation (day 3, value = 1). Data are mean RQ 6 SD, n = 3. *p,0.05;
**p,0.01
doi:10.1371/journal.pone.0105171.g004
High Throughput Generation of Hepatocyte Micro-Aggregates
PLOS ONE | www.plosone.org 7 August 2014 | Volume 9 | Issue 8 | e105171
In contrast to the aforementioned studies we demonstrate that
hepatocyte performance is directly affected by aggregate size and
the number of cells/aggregate. While aggregates of about 200 mm
diameter showed enhanced expression of hepatocyte specific
markers as compared to cells cultured in monolayers, we found
that hepatocyte function was further improved in 95613 mm
diameter aggregates. We observed more dead cells in the centre of
the 185616 mm diameter aggregates, as compared to the
95613 mm aggregates. This is in contrast to others who observed
no cell death in 180 mm diameter aggregates.[4] HepG2 cells were
found to be less prone to cell viability effects related to the
aggregate size. However, a substantial amount of dead cells was
observed in aggregates with diameters exceeding 200 mm. This is
in line with the knowledge that spheroids above 200 mm become
hypoxic at the core. [19] For HepG2 cells, a substantial amount of
dead cells was observed in the centre of the largest aggregates and
this was more pronounced at day 7 as compared to day 3.
Nevertheless no significant increase in aggregate diameter was
observed between these time points (fig. S2). This made us suggest
that the HepG2 cells did not proliferate, however we can not
completely exclude this possibility since the aggregates might
experience a further compactation between day 3 and day 7 while
proliferating. The observation that more dead cells were present at
day 7 when compared to day 3 for the larger aggregates can be
explained as follows: It takes 48–72 hours to form stable
aggregates, during that time the cells are more exposed to
nutrients and oxygen than after compactation of the spheroid
(taking place at 48–72 hours). During the next few days the oxygen
and nutrient limitations become more important/limited in the
larger spheroids, as a consequence more cells die within the larger
aggregates at the later time point.
We postulate that differences in functional performance
between 100 mm and 200 mm aggregates can be attributed to an
impaired nutrient and oxygen diffusion in the largest aggregates.
Our findings are in line with studies modeling mass transfer in
hepatocytes indicating 100 mm diameter aggregates as ‘ide-
al’.[20,21] Further decreasing the aggregate diameter to 50 mm
did not improve the functional performance of hepatocytes. The
dimensions of these aggregates might be too limited to create a
functional three dimensional organization with sufficient cells in
close contact with each other.
Gene expression of the 95613 mm aggregate was further
evaluated and compared to the gene expression of freshly isolated
hepatocytes, reflecting the gene expression in vivo. The expression
of HNF4a, an important hepatocyte specific transcription factor,
remained unchanged and increased at day 10 and 15 after
isolation. The expression of Cx32 and Cyp3A had decreased to
50–75%, indicating some loss of function, but significantly less
than in two-dimensional cultured cells. A clear upregulation of E-
cadherin, a cell adhesion molecule, expression was observed in the
aggregates. This enabled cell aggregation by increasing cell-cell
contacts and allowing compactation and is in line with data in
literature reporting this increase as necessary for cell aggrega-
tion.[22] [23]
To use aggregates as building blocks for modular tissue
engineering one needs to organize and immobilize these small
aggregate structures into a larger construct while cells remain
viable and maintain their appropriate function. Others have
described directed assembly of cell-laden microgels for the creation
of larger functional pseudo-tissues. [24,25] Here we demonstrate
that aggregates can be efficiently encapsulated in cross-linked
methacrylamide-gelatin hydrogel, without interfering with cell
viability and hepatocyte specific function. We found that
encapsulating multiple well defined primary hepatocyte aggregates
into methacrylamide gelatin hydrogel in bulk can already lead to a
viable and functional construct without the need for microencap-
sulating each individual aggregate to form a large functional tissue.
Another more practical application of predefined and controlled
cell aggregation could be the use of organ specific aggregates for
cell printing of large tissue constructs. Our group and others
showed that by using gelatin to print hepatocytes such tissue
engineered scaffolds can be made without impeding cell viability
and function. Printing, or plotting, of hepatocyte aggregates as
building blocks in predefined structures with high accuracy,
resolution and control over pore dimensions leads to further
improvement in mass transport of nutrients and metabo-
lites.[26,27] Our results clearly show that aggregate dimensions
need to be carefully considered since aggregate size and cell
number affect cell function and survival in a direct manner and
that primary hepatocytes seem to function best in aggregates
between 90–120 micrometer diameter.
In conclusion our findings show that the suggested agarose
microwells are well suited for the large scale production of uniform
hepatocyte aggregates. Moreover the results suggest that a
selection of aggregate parameters might influence the outcome
of the experiment. Our results also demonstrate that a modified
gelatin hydrogel might be well suited for the (directed) immobi-
lization of these aggregates in order to generate larger scale
constructs for a tissue engineering approach.
Supporting Information
Figure S1 Schematic overview of microwell fabrication.
(DOCX)
Figure S2 live/dead fluorescence staining of aggregates
in the 400 mm agarose chip. Pictures, recorded at 10x
magnification, represent HepG2 aggregates after 3 days (a–d)
and 7 days (e–h) of cultivation in the 400 mm agarose chip at
variable cell densities yielding aggregates with a diameter of
231 mm (a,e), 261 mm (b,f), 297 mm (c,g) and 307 mm (d,h).
(DOCX)
Figure S3 live/dead fluorescence staining of aggregates
in the 200 mm agarose chip. Pictures, recorded at 20x
magnification, represent HepG2 aggregates after 3 days (a–d)
and 7 days (e–h) of cultivation in the 200 mm agarose chip at
variable cell densities yielding aggregates with diameters of
116 mm (a,e), 142 mm (b,f), 157 mm (c,g) and 166 mm (d,h).
(DOCX)
Figure S4 Albumin secretion of primary hepatocyte
aggregates with diverse dimensions 7 days after isola-
tion. Albumin secretion in the cultivation medium during
24 hours is determined by ELISA and normalized using MTT
assay. Data are means 6 SD (n= 2).
(DOCX)
Figure S5 Induced cytochrome 3A4 activity in aggre-
gates of different diameter versus cells cultured on
tissue culture plastic. Cyp3A4 activity was quantified after
treatment with an inducing agent (hydrocortisone) using a
luciferase based assay after 7 days of isolation. Data are mean 6
SD, n=2.
(DOCX)
Figure S6 Real-time PCR analysis of HepG2 cell
aggregates with diverse dimensions. Gene expression levels
of albumin, TTR and HNF4a determined after 3 or 7 days of
cultivation in the agarose chip. RNA levels were normalized using
GAPDH as a stable housekeeping marker and the relative gene
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fold changes, compared to the gene expression of the control
culture (TCP plated cells), were determined using the 22DDCt
method. Data are mean RQ 6 SD, n= 3.
(DOCX)
Figure S7 Albumin secretion of HepG2 cell aggregates
with diverse dimensions. Albumin secretion in the cultivation
medium during 24 hours is determined by ELISA and normalized
using MTT assay. Data are means 6 SEM (n= 3).
(DOCX)
Figure S8 Transmission electron micrographs of pri-
mary hepatocytes cultured for 10 days as aggregates.
The cytoplasm of the cells displays numerous mitochondria and an
abundant RER (A). Adjoining cells show narrow contacts between
the cells and the presence of junctional structures as desmosomes
(B) and gap junctions (C).
(DOCX)
Table S1 Primer sequences for isolated mouse hepato-
cytes.
(DOCX)
Table S2 Primer sequences for HepG2 cells.
(DOCX)
Author Contributions
Conceived and designed the experiments: EG RC AVA. Performed the
experiments: EG LD. Analyzed the data: EG RC. Contributed reagents/
materials/analysis tools: AVA TB PD LD LVG. Contributed to the writing
of the manuscript: EG LD TB PD LVG AVA RC.
References
1. Shulman M, Nahmias Y (2013) Long-term culture and coculture of primary rat
and human hepatocytes. Methods Mol Biol 945: 287–302.
2. Uygun BE, Yarmush ML (2013) Engineered liver for transplantation. Curr Opin
Biotechnol 24: 893–899.
3. Jindal R, Patel SJ, Yarmush ML (2010) Tissue-Engineered Model for Real-Time
Monitoring of Liver Inflammation. Tissue Eng Part C Methods.
4. Wong SF, No da Y, Choi YY, Kim DS, Chung BG, et al. (2011) Concave
microwell based size-controllable hepatosphere as a three-dimensional liver
tissue model. Biomaterials 32: 8087–8096.
5. van Zijl F, Mikulits W (2010) Hepatospheres: Three dimensional cell cultures
resemble physiological conditions of the liver. World J Hepatol 2: 1–7.
6. Miranda JP, Rodrigues A, Tostoes RM, Leite S, Zimmerman H, et al. (2010)
Extending Hepatocyte Functionality for Drug-Testing Applications Using High-
Viscosity Alginate-Encapsulated Three-Dimensional Cultures in Bioreactors.
Tissue Engineering Part C-Methods 16: 1223–1232.
7. Ramaiahgari SC, den Braver MW, Herpers B, Terpstra V, Commandeur JN, et
al. (2014) A 3D in vitro model of differentiated HepG2 cell spheroids with
improved liver-like properties for repeated dose high-throughput toxicity studies.
Arch Toxicol.
8. Pang Y, Montagne K, Shinohara M, Komori K, Sakai Y (2012) Liver tissue
engineering based on aggregate assembly: efficient formation of endothelialized
rat hepatocyte aggregates and their immobilization with biodegradable fibres.
Biofabrication 4: 045004.
9. Mei Y, Luo H, Tang Q, Ye Z, Zhou Y, et al. Modulating and modeling
aggregation of cell-seeded microcarriers in stirred culture system for macrotissue
engineering. J Biotechnol 150: 438–446.
10. Mironov V, Visconti RP, Kasyanov V, Forgacs G, Drake CJ, et al. (2009) Organ
printing: tissue spheroids as building blocks. Biomaterials 30: 2164–2174.
11. Nichol JW, Khademhosseini A (2009) Modular Tissue Engineering: Engineering
Biological Tissues from the Bottom Up. Soft Matter 5: 1312–1319.
12. Rivron NC, Rouwkema J, Truckenmuller R, Karperien M, De Boer J, et al.
(2009) Tissue assembly and organization: developmental mechanisms in
microfabricated tissues. Biomaterials 30: 4851–4858.
13. Goncalves LA, Vigario AM, Penha-Goncalves C (2007) Improved isolation of
murine hepatocytes for in vitro malaria liver stage studies. Malar J 6: 169.
14. Rivron NC, Vrij EJ, Rouwkema J, Le Gac S, van den Berg A, et al. (2012)
Tissue deformation spatially modulates VEGF signaling and angiogenesis. Proc
Natl Acad Sci U S A 109: 6886–6891.
15. Spijker HS, Ravelli RBG, Mommaas-Kienhuis AM, van Apeldoorn AA, Engelse
MA, et al. (2013) Conversion of Mature Human beta-Cells Into Glucagon-
Producing alpha-Cells. Diabetes 62: 2471–2480.
16. Billiet T, Gasse BV, Gevaert E, Cornelissen M, Martins JC, et al. (2013)
Quantitative Contrasts in the Photopolymerization of Acrylamide and
Methacrylamide-Functionalized Gelatin Hydrogel Building Blocks. Macromol
Biosci.
17. Taguchi T, Rao Z, Ito M, Matsuda M (2011) Induced albumin secretion from
HepG2 spheroids prepared using poly(ethylene glycol) derivative with oleyl
groups. Journal of Materials Science-Materials in Medicine 22: 2357–2363.
18. Fukuda J, Nakazawa K (2005) Orderly arrangement of hepatocyte spheroids on
a microfabricated chip. Tissue Eng 11: 1254–1262.
19. Asthana A, Kisaalita WS (2012) Microtissue size and hypoxia in HTS with 3D
cultures. Drug Discov Today 17: 810–817.
20. Glicklis R, Merchuk JC, Cohen S (2004) Modeling mass transfer in hepatocyte
spheroids via cell viability, spheroid size, and hepatocellular functions.
Biotechnol Bioeng 86: 672–680.
21. Brophy CM, Luebke-Wheeler JL, Amiot BP, Khan H, Remmel RP, et al. (2009)
Rat hepatocyte spheroids formed by rocked technique maintain differentiated
hepatocyte gene expression and function. Hepatology 49: 578–586.
22. Lin RZ, Chou LF, Chien CC, Chang HY (2006) Dynamic analysis of hepatoma
spheroid formation: roles of E-cadherin and beta1-integrin. Cell Tissue Res 324:
411–422.
23. Luebke-Wheeler JL, Nedredal G, Yee L, Amiot BP, Nyberg SL (2009) E-
cadherin protects primary hepatocyte spheroids from cell death by a caspase-
independent mechanism. Cell Transplant 18: 1281–1287.
24. Du Y, Lo E, Ali S, Khademhosseini A (2008) Directed assembly of cell-laden
microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A 105:
9522–9527.
25. Du Y, Lo E, Vidula MK, Khabiry M, Khademhosseini A (2008) Method of
Bottom-Up Directed Assembly of Cell-Laden Microgels. Cell Mol Bioeng 1:
157–162.
26. Wang X, Yan Y, Pan Y, Xiong Z, Liu H, et al. (2006) Generation of three-
dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue
Eng 12: 83–90.
27. Billiet T, Gevaert E, De Schryver T, Cornelissen M, Dubruel P (2014) The 3D
printing of gelatin methacrylamide cell-laden tissue-engineered constructs with
high cell viability. Biomaterials 35: 49–62.
High Throughput Generation of Hepatocyte Micro-Aggregates
PLOS ONE | www.plosone.org 9 August 2014 | Volume 9 | Issue 8 | e105171
